A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer.
复制标题
DOI:
10.1016/j.nano.2013.02.005
复制
发表时间:
2013-10
影响因子:
5.4
通讯作者:
Hasan, Tayyaba
中科院分区:
文献类型:
--
作者:
Mir, Youssef;Elrington, Stefan A.;Hasan, Tayyaba
Targeted photodynamic therapy (TPDT) involves the administration of a photosensitizer (PS) conjugated with a targeting moiety followed by light activation. The systemic toxicity associated with conventional therapy may thus be significantly reduced in TPDT due to the dual selectivity provided by the spatial localization of the illumination as well as the target-localizing ability of the conjugate. Herein, a Photo-Immuno-Conjugate-Associating-Liposome (PICAL) for TPDT has been developed in which the FDA approved benzoporphyrin derivative monoacid A (BPD) and the Cetuximab antibody for epidermal growth factor receptor (EGFR) were associated into a stable Preformed Plain Liposome (PPL) by passive physical adsorption. Results have shown that the BPD molecules adsorbed into PICAL have stable optical behavior and a higher fluorescence quantum yield than free-BPD. The Cetuximab adsorbed into PPL selectively binds to cells that overexpress EGFR. The inhibition of EGFR signaling by PICAL has enhanced PDT-mediated ovarian cancer cell death.
登录
查看更多内容
DOI:
10.3322/caac.20114
发表时间:
2011-07
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Agostinis P;Berg K;Cengel KA;Foster TH;Girotti AW;Gollnick SO;Hahn SM;Hamblin MR;Juzeniene A;Kessel D;Korbelik M;Moan J;Mroz P;Nowis D;Piette J;Wilson BC;Golab J
通讯作者:
Golab J
DOI:
10.1038/nrc2644
发表时间:
2009-06
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.4
作者:
Dos Santos, Nancy;Allen, Christine;Bally, Marcel B.
通讯作者:
Bally, Marcel B.
影响因子:
10.3
作者:
del Carmen, MG;Rizvi, I;Hasan, T
通讯作者:
Hasan, T
影响因子:
14
作者:
Blomberg, E;Claesson, PM;Fröberg, JC
通讯作者:
Fröberg, JC